ASN
COCP icon

Advisory Services Network’s Cocrystal Pharma COCP Stock Holding History

Advisory Services Network’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$1K – 3361
2020
Q3 		$1K Buy
+100
New +$1.82K ﹤0.01% 3288

Other funds holding COCP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advisory Services Network's COCP Position: Q4 2020 in Review

Advisory Services Network sold out of Cocrystal Pharma (COCP) in Q4 2020, closing a stake of 100 shares — an estimated $1K sold.

Advisory Services Network first reported a position in COCP in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 31 funds tracked by Wall St. Rank hold COCP as of Q4 2020.

  • Advisory Services Network reported no remaining Cocrystal Pharma position as of Q4 2020 after selling out during the quarter.
  • Advisory Services Network sold 100 Cocrystal Pharma shares in Q4 2020, an estimated $1K.
  • Advisory Services Network first reported a position in Cocrystal Pharma in Q3 2020 and held it in 1 quarter.
  • Advisory Services Network's Cocrystal Pharma position peaked at $1K in Q3 2020.
  • 31 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.